PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.\', \'Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.\', \'Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.\', \'CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.\', \'MRC Biostatistics Unit, Forvie Way, University of Cambridge, Cambridge, United Kingdom.\', \'Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.\', \'Health Data Research UK, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.64827e64827
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 33704068
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
?:title
  • Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all